These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 8924933)

  • 1. [Urethral recurrence after cysto-prostatectomy for bladder tumor].
    Robert M; Burgel JS; Serre I; Guiter J; Grasset D
    Prog Urol; 1996; 6(4):558-63. PubMed ID: 8924933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Urethral tumor recurrence following radical cystoprostatectomy--an indication for primary cystoprostato-urethrectomy?].
    Gökcebay E; Riedmiller H; Stöckle M; Hohenfellner R
    Urologe A; 1989 Jul; 28(4):199-203. PubMed ID: 2763395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of urethral wash cytology in the retained male urethra after radical cystoprostatectomy.
    Lin DW; Herr HW; Dalbagni G
    J Urol; 2003 Mar; 169(3):961-3. PubMed ID: 12576822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients.
    Stein JP; Clark P; Miranda G; Cai J; Groshen S; Skinner DG
    J Urol; 2005 Apr; 173(4):1163-8. PubMed ID: 15758728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transitional cell carcinoma of the prostate in cystoprostatectomy specimens].
    Liedberg F; Chebil G; Davidsson T; Malmström PU; Sherif A; Månsson W
    Aktuelle Urol; 2003 Sep; 34(5):333-6. PubMed ID: 14566661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Membranous and penile urethral involvement in bladder cancer patients-- review of cystoprostatourethrectomy specimens].
    Shimizu T; Suzuki T; Yamanaka H; Satoh J; Suzuki K
    Hinyokika Kiyo; 1994 Oct; 40(10):869-72. PubMed ID: 7992699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
    BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder.
    Cho KS; Seo JW; Park SJ; Lee YH; Choi YD; Cho NH; Yang SC; Hong SJ
    Urol Int; 2009; 82(3):306-11. PubMed ID: 19440019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion.
    Esrig D; Freeman JA; Elmajian DA; Stein JP; Chen SC; Groshen S; Simoneau A; Skinner EC; Lieskovsky G; Boyd SD; Cote RJ; Skinner DG
    J Urol; 1996 Sep; 156(3):1071-6. PubMed ID: 8709310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
    Huguet J; Crego M; Sabaté S; Salvador J; Palou J; Villavicencio H
    Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urethral recurrence after cystoprostatectomy: implications for urinary diversion and monitoring.
    Nieder AM; Sved PD; Gomez P; Kim SS; Manoharan M; Soloway MS
    Urology; 2004 Nov; 64(5):950-4. PubMed ID: 15533484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cavernosal metastases from bladder tumour after cystoprostatectomy].
    Mondet F; Mkaouar S; Chartier-Kastler E; Bitker MO; Delcourt A; Richard F
    Prog Urol; 2003 Dec; 13(6):1330-3. PubMed ID: 15000308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravesical instillations with bacillus calmette-guérin for the treatment of carcinoma in situ involving prostatic ducts.
    Palou Redorta J; Schatteman P; Huguet Pérez J; Segarra Tomás J; Rosales Bordes A; Algaba F; Villavicencio Mavrich H
    Eur Urol; 2006 May; 49(5):834-8; discussion 838. PubMed ID: 16426729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indications for lower urinary tract reconstruction in women after cystectomy for bladder cancer: a pathological review of female cystectomy specimens.
    Stein JP; Cote RJ; Freeman JA; Esrig D; Elmajian DA; Groshen S; Skinner EC; Boyd SD; Lieskovsky G; Skinner DG
    J Urol; 1995 Oct; 154(4):1329-33. PubMed ID: 7658531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urothelial carcinoma in the prostatic urethra and prostate: current controversies.
    Liedberg F; Chebil G; Månsson W
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):383-90. PubMed ID: 17338657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recurrent urothelial cancer after resection of ureteral carcinoma].
    Kong C; Ci J; Liu T
    Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):465-7. PubMed ID: 10920948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urethral wash cytopathology for monitoring patients after cystoprostatectomy with urinary diversion.
    Knapik JA; Murphy WM
    Cancer; 2003 Dec; 99(6):352-6. PubMed ID: 14681943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
    Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
    J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [T1 G3 bladder tumors: the respective role of BCG and cystectomy].
    Pfister C; Landé P; Hervé JM; Barré P; Barbagelatta M; Camey M; Botto H
    Prog Urol; 1995 Apr; 5(2):231-7. PubMed ID: 7719369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.